Abstract
Purpose
To describe the perioperative and oncology outcomes in a series of laparoscopic or robotic partial nephrectomies (PN) for renal tumors treated in diverse institutions of Hispanic America from the beginning of their minimally invasive (MI) PN experience through December 2014.
Methods
Seventeen institutions participated in the CAU generated a MI PN database. We estimated proportions, medians, 95 % confidence intervals, Kaplan–Meier curves, multivariate logistic and Cox regression analyses. Clavien–Dindo classification was used.
Results
We evaluated 1501 laparoscopic (98 %) or robotic (2 %) PNs. Median age: 58 years. Median surgical time, warm ischemia and intraoperative bleeding were 150, 20 min and 200 cc. 81 % of the lesions were malignant, with clear cell histology being 65 % of the total. Median maximum tumor diameter is 2.7 cm, positive margin is 8.2 %, and median hospitalization is 3 days. One or more postoperative complication was recorded in 19.8 % of the patients: Clavien 1: 5.6 %; Clavien 2: 8.4 %; Clavien 3A: 1.5 %; Clavien 3B: 3.2 %; Clavien 4A: 1 %; Clavien 4B: 0.1 %; Clavien 5: 0 %. Bleeding was the main cause of a reoperation (5.5 %), conversion to radical nephrectomy (3 %) or open partial nephrectomy (6 %). Transfusion rate is 10 %. In multivariate analysis, RENAL nephrometry score was the only variable associated with complications (OR 1.1; 95 % CI 1.02–1.2; p = 0.02). Nineteen patients presented disease progression or died of disease in a median follow-up of 1.37 years. The 5-year progression or kidney cancer mortality-free rate was 94 % (95 % CI 90, 97). Positive margins (HR 4.98; 95 % CI 1.3–19; p = 0.02) and females (HR 5.6; 95 % CI 1.7–19; p = 0.005) were associated with disease progression or kidney cancer mortality after adjusting for maximum tumor diameter.
Conclusion
Laparoscopic PN in these centers of Hispanic America seem to have acceptable perioperative complications and short-term oncologic outcomes.
Similar content being viewed by others
References
Mathew A, Devesa SS, Fraumeni JF Jr, Chow WH (2002) Global increases in kidney cancer incidence, 1973–1992. Eur J Cancer Prev 11:171–178
Ljungberg B, Cowan NC, Hanbury DC et al (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58:398–406
Kaushik D, Kim SP, Childs MA et al (2013) Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors. Eur Urol 64:600–606
Mitchell RE, Gilbert SM, Murphy AM, Olsson CA, BensonMC McKiernan JM (2006) Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 67:260–264
Scherr DS, Ng C, Munver R, Sosa RE, Vaughan ED Jr, Del Pizzo J (2003) Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology. Urology 62:1007–1011
Castillo Cádiz O, Sánchez-Salas R, Vidal Moral I, Albino GD, Díaz MC, Vitagliano G, Pinto IG, Fonerón AV (2008) Nefrectomía radical laparoscópica. Nuestra experiencia en 150 pacientes consecutivos. Rev Chil de Cir 60:297–302
Rozanec JJ, Ameri C, Gueglio G (2010) Nefrectomía parcial: sí, ¿abierta o laparoscópica? Rev Argent de Urol 75:2–5
Monzó JI, García MF, Manzur E, Schell J, Finkelstein D, Albornoz J, Eraso M, Ortega R, Secin FP (2011) Experiencia inicial en cirugía laparoscópica asistida por robot en un servicio de urología de un hospital público. Rev Argent de Urol 76:46–55
García Marchiñena PA, BillordoPeres N, Bergero MA, Jurado Navarro AM, Tobía González I, Damia O, Gueglio G (2012) Resultados funcionales de la cirugía renal conservadora: comparación entre dos técnicas. Rev Argent de Urol 77:76–81
Rozanec JJ, Featherston M, Holst P, Ares J, Vallone C, Grassi A, Nolazco A (2012) Evolución del tiempo de isquemia en 130 nefrectomías parciales laparoscópicas. Rev Argent de Urol 77:184–190
Kutikov A, Uzzo RG (2009) The RENAL nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182:844–853
Sobin L, Gospodarowicz M, Wittekind C (2009) for the International Union Against Cancer (IUAC) TNM classification of malignant tumors, 7th edn. Blackwell, New York
Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663
Clavien PA, Strasberg SM (2009) Severity grading of surgical complications. Ann Surg 250:197–198
Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7:735–740
Russo P, Huang W (2008) The medical and oncological rationale for partial nephrectomy for the treatment of T1 renal cortical tumors. Urol Clin North Am 35:635–643
Weight CJ, Larson BT, Fergany AF et al (2010) Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol 183:1317–1323
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351:1296–1305
Patel SG, Penson DF, Pabla B et al (2012) National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J Urol 187:816–821
Hollenbeck BK, Taub DA, Miller DC, Dunn RL, Wei JT (2006) National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology 67:254–259
Kim SP, Shah ND, Weight CJ et al (2011) Contemporary trends in nephrectomy for renal cell carcinoa in the United States: results from a population based cohort. J Urol 186:1779–1785
Thompson RH, Kaag M, Vickers A et al (2009) Contemporary use of partial nephrectomy at a tertiary care center in the United States. J Urol 181:993–997
Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I, Permpongkosol S, Weight CJ, Kaouk JH, Kattan MW, Novick AC (2007) Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 178:41–46
Borghesi M, Brunocilla E, Schiavina R, Martorana G (2013) Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer 11:5–9
Marszalek M, Carini M, Chlosta P, Jeschke K, Kirkali Z, Knüchel R, Madersbacher S, Patard JJ, Van Poppel H (2012) Positive surgical margins after nephron-sparing surgery. Eur Urol 61:757–763
Moore LE, Wilson RT, Campleman SL (2005) Lifestyle factors, exposures, genetic susceptibility, and renal cell cancer risk: a review. Cancer Invest 23:240–255
Zisman A, Pantuck AJ, Dorey F, Chao DH, Gitlitz BJ, Moldawer N, Lazarovici D, deKernion JB, Figlin RA, Belldegrun AS (2002) Mathematical model to predict individual survival for patients with renal cell carcinoma. J Clin Oncol 20:1368–1374
Simmons MN, Gill IS (2007) Decreased complications of contemporary laparoscopic partial nephrectomy: use of a standardized reporting system. J Urol 177:2067–2073
Carneiro A, Sivaraman A, Sanchez-Salas R, Di Trapani E, Barret E, Rozet F, Galiano M, Pizzaro FU, Doizi S, Cathala N, Mombet A, Prapotnich D, Cathelineau X (2015) Evolution from laparoscopic to robotic nephron sparing surgery: a high-volume laparoscopic center experience on achieving ‘trifecta’ outcomes. World J Urol 33:2039–2044
Baumert H, Ballaro A, Shah N, Mansouri D, Zafar N, Molinié V, Neal D (2007) Reducing warm ischaemia time during laparoscopic partial nephrectomy: a prospective comparison of two renal closure techniques. Eur Urol 52:1164–1169
Acknowledgments
The uninterested collaboration of Dr. Ricardo Favaretto (Urologist at AC Camargo Cancer Center) and Dr. Fernando Caumont (Alexander Fleming Institute) is gratefully acknowledged as well as the support of the different working groups of the American Confederation of Urology (CAU). The first author thanks Sir Eduardo Eurnekian, president of America Corporation, for his help and support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Rights and permissions
About this article
Cite this article
Secin, F.P., Castillo, O.A., Rozanec, J.J. et al. American Confederation of Urology (CAU) experience in minimally invasive partial nephrectomy. World J Urol 35, 57–65 (2017). https://doi.org/10.1007/s00345-016-1837-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-016-1837-z